CRISPR: No Cutting Required

Combining a modified Cas9 enzyme with an unrelated one derived from the immune system of the sea lamprey, researchers demonstrate yet another way to edit a single DNA nucleotide.

Written byAnna Azvolinsky
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Nicked DNA being repaired by DNA ligaseWIKIMEDIA, MEDCHETaking advantage of a deaminase enzyme that introduces a single nucleotide change to DNA, researchers have created a modified CRISPR/Cas9 tool that avoids the generation of a deleterious double-stranded break, minimizes the potential for the introduction of collateral mutations, and does not require the addition of a DNA template. The new method, described today (August 4) in Science, is the second reporting of such a precise gene-editing tool.

“These deaminases solve the biggest problems with most previous genome-editing methods, including TALENSs, zinc finger nucleases, and Cas9, which is that the desired edits are in competition with random insertions an deletions via non-homologous end-joining (NHEJ),” wrote Harvard University’s George Church whose lab has also developed a deaminase-based base-editing tool. The newly described system “also “reduces the toxicity caused by double stranded breaks,” he added.

“It is always encouraging and helpful for the field when another lab replicates a major finding,” said David Liu, a professor of chemical biology at Harvard University whose lab recently described a similar technique using a different deaminase enzyme. “The authors here were also able to demonstrate that this gene editing strategy works in cells.”

With the CRISPR/Cas9 system, researchers ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • head shot of blond woman wearing glasses

    Anna Azvolinsky received a PhD in molecular biology in November 2008 from Princeton University. Her graduate research focused on a genome-wide analyses of genomic integrity and DNA replication. She did a one-year post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City and then left academia to pursue science writing. She has been a freelance science writer since 2012, based in New York City.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies